Attorneys argue FDA regulation of tobacco before Supreme Court.
نویسنده
چکیده
Justice Department attorneys presented their arguments as to whether the US Food and Drug Administration (FDA) can regulate tobacco before a skeptical US Supreme Court in early December. The case, named FDA versus Brown & Williamson Tobacco is a major part of the Clinton administration’s attempts to reign in the politically powerful tobacco industry and to promote public health by reducing the number of people who smoke. The brainchild of former US FDA Commissioner David Kessler, the suit seeks to regulate cigarettes on the theory that the nicotine it contains has drug-like properties, despite the fact that the FDA has turned down chances to regulate tobacco in decades past. At that time, the agency claimed it had no authority to regulate cigarettes. However, the FDA said it has changed its policy because of new revelations found in documents the tobacco companies were forced to release. Attorneys for the tobacco companies argue that cigarette makers make no claims of health benefit for their product, and therefore, the FDA has no jurisdiction over it. Forty states backed the FDA’s attempt to regulate tobacco, filing a friend-of-the-court brief that referred to rising rates of teenage smoking and the attempts by the tobacco industry to conceal the deadly nature of its products. Indeed, the FDA attempted with its first regulations to stem the teen smoking tide. It would have required that those who sell cigarettes and other tobacco products check the identification of buyers under the age of 27 and prohibit cigarette vending machines everywhere except places where only adults could go. The government won its case in federal court, but it was reversed in the 4th Circuit Court of Appeals, which ruled that the agency lacked the regulatory power it had assumed. “In the 60 years following the passage of the act (the act that established the FDA’s authority), the FDA has repeatedly informed Congress that cigarettes marketed without therapeutic claims do not fit within the scope of the act,” the Court noted in its opinion. US Supreme Court justices seemed no more convinced during the hour-long arguments before it in early December. According to the New York Times, Justice Sandra Day O’Connor said several times that regulating smoking “just doesn’t fit” within the agency’s statutory authority. She also asked Solicitor General Seth Waxman whether under his theory, the FDA should regulate horror movies “because so many people go to them to get scared and get their adrenaline pumping.”
منابع مشابه
Exemption from federal preemption of state and local cigarette and smokeless tobacco requirements; revocation. Food and Drug Administration, HHS. Final rule.
The Food and Drug Administration (FDA) is revoking its regulation governing the exemption from Federal preemption of State and local medical device requirements for the sale and distribution of cigarettes and smokeless tobacco to children and adolescents. This action is being taken in response to the Supreme Court Decision of March 21, 2000, in which the court held that Congress has not given ...
متن کاملThe FDA may not regulate tobacco products as "drugs" or as "medical devices".
Professor Richard Merrill contends that the Federal Food, Drug, and Cosmetic Act does not grant the FDA regulatory authority over cigarettes and smokeless tobacco products. The fact that Congress did not expressly deny the FDA regulatory authority over tobacco cannot, Professor Merrill argues, be used to infer such authority. This inference is particularly inappropriate in the case of tobacco...
متن کاملIs tobacco a drug? Administrative agencies as common law courts.
Professor Cass Sunstein argues that the FDA has the authority to regulate tobacco products. He considers the text of the Federal Food, Drug, and Cosmetic Act, which supports the FDA assertion, and the context of its enactment, which argues against the FDA. He resolves the tension between text and context in favor of FDA jurisdiction by turning to the emerging role of administrative agencies. ...
متن کاملThe impact of Wyeth v. Levine on FDA regulation of prescription drugs.
In Wyeth v. Levine, decided in March, 2009, the United States Supreme Court concluded that the plaintiff's failure to warn claim against the makers of the drug Phenergan was not impliedly preempted by the Food, Drug and Cosmetic Act. In doing so, the Court rejected the argument of the U.S. Food and Drug Administration (FDA) that tort claims of this nature stand as an obstacle to federal regulat...
متن کاملAmericans with disabilities act: recent and pending u.s. Supreme court decisions and implications for spine professionals.
This article highlights recent and pending United States Supreme Court cases interpreting employment provisions of the Americans with Disabilities Act and discusses their implications for spine professionals. The implications include how Spine readers approach evaluations of employees and job applicants with disabilities and workplace accommodations in light of the recent decisions. The cases p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Circulation
دوره 101 2 شماره
صفحات -
تاریخ انتشار 2000